Original Source(s)
Related Content
Rare COVID Vaccine Clotting Linked to Adenoviral Protein
Antibody proteomics and immunogenetics identify adenoviral protein VII as the trigger of PF4-targeting antibodies
May 13, 2026
-
3 min
Complex Hematologic Malignancy Management in a TP53-Mutated Patient: Balancing Disease Control and Quality of Life
Cytogenetic and molecular testing revealed a complex karyotype and a TP53 mutation, placing her disease in an adverse-risk category.